Psyence Biomedical Ltd PBM
Annual
Quarterly
No annual revenue total was found in PSYENCE BIOMEDICAL LTD's SEC filings.
Psyence Biomedical Ltd (PBM) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$3.7 million.
Revenue
—
Net income
$1.01M
+102.0% vs prior year
Operating cash flow
$-3.73M
-26.8% vs prior year
Free cash flow
$-3.74M
-26.9% vs prior year
EPS
$5.24
+100.1% vs prior year
Dividend per share
None
Shares outstanding
2.29M
+303.7% vs prior year
Net cash
$-9.71M
FY 2024
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBM (Nasdaq), PBMWW (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1985062
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
|---|---|---|
| Net income | $1.0M | -$51.2M |
| Diluted EPS | $5.24 | -$4,674.25 |
| Operating cash flow | -$3.7M | -$2.9M |
| Free cash flow | -$3.7M | -$3.0M |
| Total assets | $7.3M | $1.1M |
| Total liabilities | $594,366 | $12.1M |
| Stockholders' equity | $6.7M | -$11.0M |
| Cash and investments | $6.1M | $733,188 |
| Total debt | — | $10.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Sep 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
All 170 Psyence Biomedical Ltd SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.